National Center for Advancing Translational Sciences

Therapeutic Approaches: Biologics, Small Molecules, Biomarkers, Antibodies, Stem Cells, Gene Therapy, Drug Delivery, Drug Devices, , Covid-19

Therapeutic Areas of Expertise: Cardiology, Gene-Therapy, Immunology, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Oncology, Psychiatric Disorders, Pain, Virology

Center/Program Highlights:

NCATS strives to develop innovations to reduce, remove, or bypass costly and time-consuming bottlenecks in the translational research pipeline in an effort to speed the delivery of new drugs, diagnostics, and medical devices to patients. NCATS unifies programs in the following three areas: Clinical and Translational Science, Rare Disease Research and Therapeutics, and Re-engineering Translational Sciences.

Sources of Funding: Industry Partnerships, Disease Foundations, Federal/State,


Institutional Affiliation(s): National Institutes of Health

One Democracy Plaza, 9th Floor
6701 Democracy Blvd, MSC 4874
Maryland, 20892-4874
United States

Center/Program Start Date: 2011

Number of Employees: 300